IBMS BoneKEy | Perspective

An update on the pharmacology of bisphosphonates and analogues with lower bone affinity

Fraser P Coxon



DOI:10.1138/20080341

Abstract

It has become clear that the pharmacological characteristics of nitrogen-containing bisphosphonates (N-BPs) are the result of both their ability to inhibit farnesyl diphosphate synthase in osteoclasts and their affinity for bone mineral. Both of these properties differ for every N-BP, helping to explain the differences in both potency and duration of action within this class of drugs. The mechanistic basis for the different characteristics of N-BPs is highlighted in this review. In addition, numerous N-BP analogues have been synthesized that exhibit different target enzyme specificity and much larger variations in bone affinity than can be achieved with N-BPs. These are also discussed, with particular emphasis on the potential applications and advantages that such compounds could offer over existing N-BPs.


Creative Commons License This work is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 3.0 United States License.